A recent study further suggested that P2X7 promotes cell migration and metastasis via increasing the extracellular vesicles production in tamoxifen-resistant breast cancers (87), further indicating the possibility to target P2X7 as a strategy for alleviating drug resistance in breast cancers. This evidence concerns the gene P2RX7 and breast carcinoma.